Related Experiment Video

Updated: Oct 13, 2026

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

Characteristics of Malaysian infants with biliary atresia and neonatal hepatitis

S Karnameedi1, C T Lim

  • 1Department of Paediatrics, Faculty of Medicine, University Malaya, Kaula Lumpur.

The Medical Journal of Malaysia
|September 1, 2000
PubMed

Insights

Infants with neonatal hepatitis or biliary atresia in Malaysia often present late. Early diagnosis of these cholestatic disorders is crucial for better infant survival rates.

Area of Science:

  • Pediatrics
  • Hepatology
  • Neonatology

Background:

  • Cholestatic disorders of infancy, including neonatal hepatitis and biliary atresia, are not well-studied in Malaysia.
  • These conditions significantly impact infant health and survival.

Purpose of the Study:

  • To analyze and compare the clinical features of neonatal hepatitis and biliary atresia in Malaysian infants.
  • To identify challenges in differentiating these conditions and suggest improvements in medical care and public awareness.

Main Methods:

  • Retrospective study of 93 infants diagnosed with cholestatic disorders between 1982 and 1991 at University Hospital, Kuala Lumpur.
  • Comparison of clinical presentation, demographics, and physical findings between biliary atresia and neonatal hepatitis groups.

Main Results:

  • Biliary atresia (38%) and neonatal hepatitis (62%) were identified. Neonatal hepatitis showed a male preponderance (P=0.020).
  • Significant differences observed in age of presentation, prolonged jaundice, alcoholic stools, liver, and spleen size between the two groups.
  • Considerable overlap in clinical features made differentiation difficult, with late presentation noted for infants with cholestasis.

Conclusions:

  • Clinical differentiation between neonatal hepatitis and biliary atresia in infants is challenging due to overlapping features.
  • Late presentation of cholestatic disorders compromises infant survival.
  • Emphasizing these conditions in medical training and increasing public awareness are vital for improving patient outcomes.

More Related Videos

Isolation of Neonatal Extrahepatic Cholangiocytes07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...